Sign inJoin waitlistJoin the waitlist

Kathryn Lurain

Associate Professor · Ohio State University Hospital

Credentials: · · · · · · ·

History

Ohio State University Hospital
Present

Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2015–2018
Internal Medicine
University of Chicago Medical Center
2012–2015
University of Virginia School of Medicine
2008–2012

Research

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study
JAMA Oncology · 2019 · 205 citations
Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA
Proceedings of the National Academy of Sciences of the United States of America · 2018 · 150 citations
Viral, immunologic, and clinical features of primary effusion lymphoma
Blood · 2019 · First of 18 authors · 116 citations

Ramya Ramaswami
50 papers
Robert Yarchoan
47 papers
TU
Thomas Uldrick
30 papers
Hao-Wei Wang
10 papers
MP
Mark Polizzotto
10 papers
PG
Priscila Hermont Barcellos Goncalves
9 papers
Ralph Mangusan
9 papers
Armando Filie
7 papers
ES
Elad Sharon
7 papers
Elaine Jaffe
7 papers
Stefania Pittaluga
7 papers
Constance Yuan
5 papers

Clinical trials

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2016–2024
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028